Clin2
NCT05664516Possibly a fitRecruiting

Oxytocin treatment study for binge eating disorder adults

Binge-eating Disorder

Part of Mental health clinical trials.

This Phase 2 trial tests whether oxytocin (a hormone-like medication) can reduce binge-eating symptoms in adults with binge-eating disorder (including related conditions like bulimia or certain feeding/eating disorders). You may be eligible if your symptoms match the trial’s specific diagnosis rules and you can safely take the study medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You’re age 18 to 70
  • Your body mass index (BMI) is 18.5 or higher
  • You have binge-eating disorder, or a closely related eating disorder that fits the trial’s rules
  • No active substance use disorder in the past 6 months (or concerning signs on screening)
  • Your heart, thyroid, and other health tests must be in a safe range, and you can’t have certain medical conditions
  • You’re not pregnant or breastfeeding, and you can use contraception if needed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07042672Recruiting
Therapy and medication for binge eating in obesity

This trial tests whether a medication (liraglutide) plus behavioral counseling helps people with severe obesity and binge-eating disorder reduce binge episodes, lose weight, and improve coping. Participants will receive either liraglutide or placebo, along with group therapy sessions.

Bergen, Vestland
NCT05726721Recruiting
Study of treatment targets for binge eating disorder

This trial studies how binge eating disorder behaves during treatment and compares patterns over time. It may help by improving future treatment approaches for people with binge eating disorder.

Aarhus, Central Jutland
NCT06847399Recruiting· Phase 2
Tirzepatide for Binge Eating Disorder

This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.

Baltimore, Maryland
NCT07698132Recruiting
Psychotherapy for binge eating disorder

This trial tests three levels of psychotherapy (high, medium, and low intensity) to find which works best for binge eating disorder. It aims to help you stop binge episodes and improve your relationship with food.

Ballerup Municipality, Capital Region
NCT05149859Recruiting
Binge eating and severe obesity treatment after screening

This study looks at people with obesity, including those with binge eating disorder (BED). It compares groups based on their binge-eating questionnaires and tests a care approach at obesity and mental-health clinics.

Québec
NCT07212673Recruiting
Online therapy for binge eating disorder

This study tests a digital program that combines cognitive-behavioral therapy with mindfulness training to help people with binge eating disorder. It may help reduce binge eating episodes and improve your relationship with food.

The Bronx, New York

Hear when a new Binge-Eating Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.